Protalix BioTherapeutics, Inc. (PLX)
 NYSEAMERICAN: PLX · Real-Time Price · USD
 2.260
 -0.110 (-4.64%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees 
 213
Change (1Y) 
 5
Growth (1Y) 
 2.40%
Revenue / Employee 
 $290,836
Profits / Employee 
 $29,460
Market Cap 
180.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 213 | 5 | 2.40% | 
| Dec 31, 2023 | 208 | 11 | 5.58% | 
| Dec 31, 2022 | 197 | -9 | -4.37% | 
| Dec 31, 2021 | 206 | -1 | -0.48% | 
| Dec 31, 2020 | 207 | 11 | 5.61% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
PLX News
- 13 days ago - Why Is Protalix BioTherapeutics Stock Falling On Friday? - Benzinga
- 13 days ago - Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU - GlobeNewsWire
- 7 weeks ago - Protalix BioTherapeutics to Present at Investor Summit Virtual - Accesswire
- 2 months ago - Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 2 months ago - Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp - Seeking Alpha
- 2 months ago - Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 - PRNewsWire